Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1000 participants
OBSERVATIONAL
2019-08-23
2031-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transcatheter Repair of Tricuspid Regurgitation With Edwards PASCAL Transcatheter Valve Repair System
NCT04614402
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
NCT04097145
Edwards PASCAL Transcatheter Valve Repair System Registry
NCT04443218
Mitralign Percutaneous Annuloplasty System for Chronic Functional Mitral Valve Regurgitation
NCT01740583
Efficacy of MitraCLip Vs. PASCAL for the TrEAtment of MitraL REgurgiTation in an All-comer Population
NCT06634121
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Edwards PASCAL Transcatheter Valve Repair System and Edwards PASCAL Precision Transcatheter Valve Repair System
Transcatheter Valve Repair with Edwards PASCAL and PASCAL Precision System
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient is willing and able to attend all follow-up visits and to perform all tests
3. Provision of written informed consent
Exclusion Criteria
2. Non-elective or emergency TEER procedure for mitral regurgitation
3. Patients in ICU prior to the index procedure
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Edwards Lifesciences
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philipp Lurz, Prof.Dr.med.
Role: PRINCIPAL_INVESTIGATOR
Johannes Gutenberg University Mainz
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medizinische Universität Wien/AKH Wien
Vienna, , Austria
Universitäts-Herzzentrum Freiburg Campus Bad Krozingen
Bad Krozingen, Baden-Wurttemberg, Germany
Universität Tuebingen
Tübingen, Baden-Wurttemberg, Germany
Uniklinikum Ulm
Ulm, Baden-Wurttemberg, Germany
Uniklinikum Erlangen
Erlangen, Bavaria, Germany
Medizinische Klinik I- Campus Grosshadern
München, Bavaria, Germany
Immanuel Klinikum Bernau
Bernau bei Berlin, Brandenburg, Germany
Universitätsklinikum Giessen UKGM
Giessen, Hesse, Germany
Universitaeres Herzzentrum Goettingen
Göttingen, Lower Saxony, Germany
Westdeutsches Herzzentrum / Uniklinik Essen
Essen, Nordrhine Westfalia, Germany
Contilia Herz- und Gefäßzentrum,Elisabeth-Krankenhaus Essen
Essen, Nordrhine Westfalia, Germany
Herz- und Diabeteszentrum NRW - Bad Oeynhausen
Bad Oeynhausen, North Rhine-Westphalia, Germany
Universitätsklinikum Bonn
Bonn, North Rhine-Westphalia, Germany
Herzzentrum Universitaetsklinik Herzzentrum Universitaetsklinik Cologne
Cologne, North Rhine-Westphalia, Germany
St.-Johannes-Hospital
Dortmund, North Rhine-Westphalia, Germany
Universitätsmedizin der Johannes Gutenberg Universität Mainz
Mainz, North Rhine-Westphalia, Germany
Helios Klinikum Siegburg
Siegburg, North Rhine-Westphalia, Germany
Herzzentrum Universitätsklinik Dresden
Dresden, Saxony, Germany
Universitäres Herzzentrum Lübeck, Universitätsklinikum Schleswig-Holstein
Lübeck, Schleswig-Holstein, Germany
Zentralklinik Bad Berka GmbH
Bad Berka, , Germany
Charité Berlin
Berlin, , Germany
Charité Berlin
Berlin, , Germany
MVZ-CCB
Frankfurt, , Germany
Universitares Herzzentrum Hamburg
Hamburg, , Germany
Kath. Marienkrankenhaus Hamburg GmbH
Hamburg, , Germany
Universitätsklinikum Schleswig-Holstein, Campus Kiel
Kiel, , Germany
Heart Centre of the University Leipzig
Leipzig, , Germany
Hygeia Hospital
Athens, , Greece
IRCCS Ospedale San Raffaele
Milan, Lombardy, Italy
Ospedale del Cuore G. Pasquinucci Massa
Massa, , Italy
IRCCS Policlinico San Donato
San Donato Milanese, , Italy
St. Antonius Ziekenhuis
Nieuwegein, , Netherlands
Erasmus MC
Rotterdam, , Netherlands
The Cardinal Stefan Wyszyński, Institute of Cardiology
Warsaw, , Poland
Hospital Alvaro Cunqueiro
Vigo, , Spain
Inselspital Bern
Bern, , Switzerland
Wythenshawe Hospital
Manchester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.